Transcode Therapeutics, Inc.
Pharmaceutical Preparations · BOSTON · MA
Moderate confidence (50%)
Updated Oct 13, 2026, 12:05 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Transcode Therapeutics, Inc. received a delisting notice from its exchange (May 19, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Transcode Therapeutics, Inc. received a delisting notice from its exchange
May 19, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On May 19, 2026, TransCode Therapeutics, Inc. (the Company ) received a deficiency letter from the Listing Qualifications Department (the Staff ) of the Nasdaq Stock Market ( Nasdaq ) notifying the Company that it is not in compliance with the minimum stockholders equity requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires companies listed on the Nasdaq Capital Market to maintain stockholders equity of at least $2,500,000 (the Stockhol…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker RNAZ on Nasdaq.
- SEC CIK
- 0001829635
- Website
- —
- —
- Headquarters
- BOSTON, MA
- Also known as
- —
- Legal entities
- Transcode Therapeutics, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Transcode Therapeutics, Inc. — Pharmaceutical Preparations (SIC 2834) — BOSTON, MA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On May 19, 2026, TransCode Therapeutics, Inc. (the Company ) received a deficiency letter from the Listing Qualifications Department (the Staff ) of the Nasdaq Stock Market ( Nasdaq ) notifying the Company that it is not in compliance with the minimum stockholders equity requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires companies listed on the Nasdaq Capital Market to maintain stockholders equity of at least $2,500,000 (the Stockhol…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:12 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:34 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:04 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:02 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:44 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.